Physician

Aaron Wood Tungate, P.A.

According to 2025 Medicare claims, Aaron Tungate, P.A. (NPI: 1518911106) practices physician assistant in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS (NPI: 1275838732; TIN: 756002868) and primary practice location at 76104-2410. Tungate is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

Tungate's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 534 HCPCS/CPT codes, and received $39,763 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,004 prescription claims across 655 beneficiaries totaling $616,539 in drug costs, led by Eliquis (Apixaban). 2018 DME data shows 12 claims. Open Payments data shows 1 records totaling $14. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $40,934 and ending at $39,763. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $113,462 to $616,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	582	995	$40,934
2016	286	504	$19,982
2017	131	199	$10,696
2018	433	841	$43,940
2019	480	996	$46,738
2020	437	857	$33,922
2021	369	972	$45,316
2022	376	989	$47,904
2023	350	662	$31,475
2024	363	534	$39,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	306	1,323	$113,462
2016	301	1,489	$87,231
2017	350	2,013	$151,646
2018	399	1,944	$148,347
2019	414	2,349	$217,158
2020	439	2,420	$331,530
2021	454	2,518	$415,661
2022	454	2,526	$482,349
2023	564	2,619	$568,431
2024	655	3,004	$616,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	84	$3,956
2016	N/R	85	$4,529
2017	N/R	52	$2,212
2018	N/R	12	$489
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	66	66	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	330	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	46	50	$57
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	21	21	$49
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	52	52	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	335	19,366	$374,286
Jardiance	Empagliflozin	84	3,530	$69,087
Entresto	Sacubitril/Valsartan	35	2,440	$51,581
Xarelto	Rivaroxaban	32	2,000	$35,860
Repatha Sureclick	Evolocumab	21	924	$17,897

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$14	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Wood Tungate, P.A.?

Tedicare shows public-source Medicare data for Aaron Wood Tungate, P.A. (NPI 1518911106), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Wood Tungate, P.A. have ACO affiliation data?

Aaron Wood Tungate, P.A. is shown with ACO affiliation data for UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Aaron Wood Tungate, P.A.?

Aaron Wood Tungate, P.A. is linked to UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS (billing NPI 1275838732) in the available physician profile data.

Does Aaron Wood Tungate, P.A. have Open Payments data?

Aaron Wood Tungate, P.A. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.